Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Jesse Keller"'
Autor:
Shamia Hoque, Brian J Chen, Martin W Schoen, Kenneth R Carson, Jesse Keller, Bartlett J Witherspoon, Kevin B Knopf, Y Tony Yang, Benjamin Schooley, Chadi Nabhan, Oliver Sartor, Paul R Yarnold, Paul Ray, Laura Bobolts, William J Hrushesky, Michael Dickson, Charles L Bennett
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box
Externí odkaz:
https://doaj.org/article/db22cc567bfb42b08476116e945c2620
Autor:
Abigail L. Carlson, Daniel M. Pastula, Amy J. Lambert, J. Erin Staples, Atis Muehlenbachs, George Turabelidze, Charles S. Eby, Jesse Keller, Brian Hess, Richard S. Buller, Gregory A. Storch, Kathleen Byrnes, Louis Dehner, Nigar Kirmani, F. Matthew Kuhlmann
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 5, Pp 893-897 (2018)
Heartland virus is a suspected tickborne pathogen in the United States. We describe a case of hemophagocytic lymphohistiocytosis, then death, in an immunosuppressed elderly man in Missouri, USA, who was infected with Heartland virus.
Externí odkaz:
https://doaj.org/article/60cccd65c2354d78b9a2bce399e3af5e
Autor:
Sahaja Acharya, MD, Mustafaa Mahmood, BS, Daniel Mullen, DDS, MS, Deshan Yang, PhD, Christina I. Tsien, MD, Jiayi Huang, MD, Stephanie M. Perkins, MD, Keith Rich, MD, Michael Chicoine, MD, Eric Leuthardt, MD, Joshua Dowling, MD, Gavin Dunn, MD, PhD, Jesse Keller, MD, Clifford G. Robinson, MD, Christopher Abraham, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 4, Pp 572-580 (2017)
Purpose: Stereotactic radiosurgery (SRS) in combination with immunotherapy (IMT) or targeted therapy is increasingly being used in the setting of melanoma brain metastases (MBMs). The synergistic properties of combination therapy are not well underst
Externí odkaz:
https://doaj.org/article/263aea1684d249dc8f440ca130c8b6ea
Autor:
Martin W. Schoen, Mark A. Fiala, Suhong Luo, David C. Calverley, Kenneth R. Carson, Nicole M. Kuderer, Tzu-Fei Wang, Jesse Keller, Kristen M. Sanfilippo, Tanya M. Wildes, Theodore S. Thomas, Joseph Mikhael, Brian F. Gage
Publikováno v:
Am J Hematol
BACKGROUND: Venous thromboembolism (VTE) is a common cause of morbidity and mortality among patients with multiple myeloma (MM). The International Myeloma Working Group (IMWG) developed guidelines recommending primary thromboprophylaxis in those iden
Autor:
George Ansstas, Stephanie M. Perkins, Tanner M. Johanns, R.I. Chin, Leonel Hernandez-Aya, Jesse Keller, Jiayi Huang, Cliff G. Robinson, Albert H. Kim, Keith M. Rich, Christopher Abraham, Michael R. Chicoine, Joshua L. Dowling, Gavin P. Dunn, K. Chen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e565-e566
Purpose/Objective(s) Immune checkpoint inhibitors (CPIs) and BRAF inhibitors (BIs) are standard treatments for metastatic melanoma and have intracranial activity against melanoma brain metastases (MBMs). However, optimal use of CPI/BI with radiation
Autor:
Laura Rose Bobolts, Benjamin Schooley, Bartlett J. Witherspoon, Jesse Keller, Paul R. Yarnold, Brian J. Chen, Michael Dickson, Chadi Nabhan, Kenneth R. Carson, Martin W. Schoen, Kevin B. Knopf, Shamia Hoque, Y. Tony Yang, Oliver Sartor, William J. M. Hrushesky, Paul Ray, Charles L. Bennett
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box
Autor:
Amy Zhou, Manik Amin, William C. Chapman, Benjamin R. Tan, Jesse Keller, Ashley Morton, Kathryn J. Fowler, Maria B. Doyle, Elizabeth M. Brunt, Neeta Vachharajani, Nikolaos A. Trikalinos
Publikováno v:
Journal of the National Comprehensive Cancer Network. 16:1193-1199
Background: Combined hepatocellular-cholangiocarcinoma tumors (cHCC-CCA) are a heterogeneous group of rare malignancies that have no established optimal treatment. Patients and Methods: We identified patients with cHCC-CCA treated at a tertiary cente
Autor:
Atis Muehlenbachs, Kathleen Byrnes, Louis P. Dehner, Nigar Kirmani, Brian Hess, F. Matthew Kuhlmann, J. Erin Staples, Amy J. Lambert, Abigail L. Carlson, Daniel M. Pastula, George Turabelidze, Charles S. Eby, Jesse Keller, Richard S. Buller, Gregory A. Storch
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 24, Iss 5, Pp 893-897 (2018)
Emerging Infectious Diseases, Vol 24, Iss 5, Pp 893-897 (2018)
Heartland virus is a suspected tickborne pathogen in the United States. We describe a case of hemophagocytic lymphohistiocytosis, then death, in an immunosuppressed elderly man in Missouri, USA, who was infected with Heartland virus.
Autor:
Thalachallour Mohanakumar, Jesse Keller, Donna Phelan, Michael Slade, Brenda J. Grossman, Jun Zou, Rizwan Romee
Publikováno v:
Bone Marrow Transplantation. 52:898-901
Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation
Autor:
Allison Weinkle, Benjamin H. Kaffenberger, John C. Trinidad, Elizabeth N. Ergen, Jesse Keller, Lucia Seminario-Vidal
Publikováno v:
Journal of the American Academy of Dermatology. 82(3)